Figure 5 | Scientific Reports

Figure 5

From: Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients

Figure 5

Explorative prognostic model including C18 Cer and CTC positivity. Kaplan Meier curves and log-rank test are shown. The blue line represents patients with C18 Cer < 30 ng/mL and CTC-negative, the green line represents patients with C18 Cer ≥ 30 ng/mL or CTC-positive, the yellow line represents patients with C18 Cer ≥ 30 ng/mL and CTC-positive.

Back to article page